Indication

Infertility secondary to progesterone deficiency

Infertility secondary to progesterone deficiency refers to impaired reproductive capacity in females resulting from inadequate circulating levels, reduced duration, or impaired endometrial response to progesterone during the luteal phase of the ovarian cycle. Read more about Infertility secondary to progesterone deficiency

3 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Infertility secondary to progesterone deficiency therapies.

Showing 1–3 of 3 drugs

Filter & compare in the drug finder →Opens the drug finder with Infertility secondary to progesterone deficiency preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Infertility secondary to progesterone deficiency.

Infertility secondary to progesterone deficiency refers to impaired reproductive capacity in females resulting from inadequate circulating levels, reduced duration, or impaired endometrial response to progesterone during the luteal phase of the ovarian cycle.

Affecting the female reproductive endocrine and uterine systems, this condition is classically characterized by corpus luteum dysfunction—often described clinically as luteal phase deficiency or defect—that results in defective secretory transformation of the endometrium.

Pathophysiologically, the insufficient hormonal exposure creates an asynchronous or non-receptive endometrial environment, which impedes blastocyst implantation and impairs the maintenance of early pregnancy.

Personalize your experience

Follow Infertility secondary to progesterone deficiency and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it